MATTHEW FOREMAN RESEARCH LIMITED

Executive Summary

MATTHEW FOREMAN RESEARCH LIMITED exhibits excellent financial health as a micro-entity with strong liquidity, zero liabilities, and steady net asset growth. The company’s current financial profile shows no signs of distress, reflecting a stable and well-managed business in the artistic creation sector. To sustain this wellness, the business should maintain its healthy cash flow and consider measured growth strategies to enhance future resilience.

MATTHEW FOREMAN RESEARCH LIMITED - Analysis Report

Company Number: 13972351

Analysis Date: 2025-07-29 19:37 UTC

Financial Health Assessment of MATTHEW FOREMAN RESEARCH LIMITED

---

1. Financial Health Score: A-

Explanation:
The company demonstrates strong liquidity, zero current liabilities, and steady growth in net assets over its operational years. As a micro-entity with no debt and positive working capital, the financial “vitals” indicate a healthy condition. The absence of employees and fixed assets aligns with the nature of an artistic creation business, which often relies on intellectual property and minimal physical assets. The score reflects excellent financial stability but acknowledges limited scale and absence of diversification.

---

2. Key Vital Signs:

Metric	2025 (£)	Interpretation
Fixed Assets	0	No long-term assets; typical for service/art business
Current Assets	50,544	Healthy cash or receivables, good liquidity
Current Liabilities	0	No short-term debts or payables, no liquidity stress
Net Current Assets	50,544	Strong working capital, “healthy cash flow” buffer
Total Net Assets	50,544	Positive equity, growing year-on-year
Shareholders Funds	50,544	Fully funded by equity, no debt leverage
Employees	0	Sole trader style operation, low overhead

• Growth Trend: Net assets rose from £21k in 2022 to £50.5k in 2025, indicating profitable retention or capital injection.
• Liquidity Status: Current assets with no liabilities means excellent short-term financial health.
• Leverage: No borrowing or creditors detected — no “symptoms of financial distress” due to over-indebtedness.
• Scale: Micro-entity size with low operational complexity.

---

3. Diagnosis:

The company’s financial “vitals” portray a business in robust health, akin to a patient with steady vital signs and no signs of underlying illness. The net asset growth suggests profitability or shareholder funding, with all capital held as equity. The absence of liabilities or creditors points to no external financial burdens, implying the business is self-sustaining or newly capitalized.

As a micro-entity in artistic creation, the zero fixed assets and lack of employees are not concerning but consistent with the industry profile. The director is the sole controller, reinforcing a tightly managed business structure.

No “symptoms of distress” such as overdue filings, negative equity, or liquidity crunch are present. The company is well-positioned for stability, though its small size limits scalability and resilience to market shocks.

---

4. Recommendations:

• Maintain Strong Cash Management: Continue to preserve the strong liquidity position. Avoid unnecessary liabilities that could cause cash flow strain.
• Consider Growth Opportunities: Explore strategic investment in fixed assets or hiring if expanding operations to strengthen business capacity.
• Monitor Market and Revenue Streams: As a small, single-director company, ensure steady income through diversified artistic projects or client base to prevent revenue volatility.
• Prepare for Scaling: When growth warrants, consider formalizing governance or seeking external financing to enhance operational flexibility.
• Regular Financial Reviews: Keep reviewing financial health periodically, especially before any major business decisions or investments.

---